Of the 10 patients with tRCC, 3 were shown to have PD-L1+ tumor cells and 9 PD-L1+ tumor-infiltrating cells. This evidence concerns the gene CD274 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.